Research Trial for Prurigo Nodularis (40 Weeks)

Adults aged 18-80 years old with a clinical diagnosis of prurigo nodularis (PN) for at least 3 months, may qualify to participate. Individuals must have a minimum of 20 PN lesions in total on both legs, and/or both arms, and/or their trunk (on at least 2 body surface areas). Having failed a 2-week course of medium-to-superpotent topical corticosteroids (TCS) or when TCS are not medically advisable, is also required. Individuals will be asked to rate their worst itch daily, on a scale of 0 to 10.

Participants will receive investigational medication (active study drug) or placebo, via injection. Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 40 weeks and involve about 7 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Prurigo Nodularis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more